Email Print this page Bookmark this page

LACRISERT® Sample Request

Thank you for interest in receiving LACRISERT® samples for your patients. Please follow the following steps.

Step 1: Enter the required contact information below. Also, enter the quantity requested (limit of 5 sample packs).
Step 2: Once the information is complete, press the submit button to view and print your request form.
Step 3: Please sign and date the form.
Step 4: Fax the request to (908) 927-1926 or mail to:
  Valeant Pharmaceuticals North America
Attn: Customer Service
700 Route 202/206, Bridgewater, NJ 08807
Zip Code*
(NDC 25010-805-08) LACRISERT® 5mg 10 Inserts per pack Quantity Request*:
Is this your first LACRISERT® sample request via the web site?
Have you received LACRISERT® samples from a sales representative?
Have you prescribed LACRISERT® previously?
How many dry eye patients do you treat on average per month?
* Indicates required information.
YES, I would like Aton Pharma, Inc. to send me periodic updates about LACRISERT®.
Protecting Your Privacy
In order to provide you with a better Web site experience and better features in the future, we ask you for your e-mail address. If you provide this data, you agree to allow Aton Pharma, Inc. to link your e-mail address to anonymous (non−personally-identifiable) information that you may have given us previously, or that may have been collected on other Aton Pharma, Inc. Web sites. We will not sell your e-mail address, and you will not receive e-mail from us that you have not agreed to receive.

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

sample request using Lacrisert video patient tip sheet
© 2011 ATON Pharma, a Division of Valeant Pharmaceuticals North America LLC. All Rights Reserved.